Halle Capital Management and Trilantic North America, both private equity firms, have lead a new round of financing in Rarebreed Veterinary Partners, a technology-enabled veterinary services platform.
“At Rarebreed, we are passionate about taking care of the people who take care of animals,” said Dan Espinal, CEO of Rarebreed Veterinary Partners. “We are excited to announce this new round of funding, which will allow us to continue providing an exceptional work experience for animal healthcare professionals in our network, while expanding our platform to reach even more people who have dedicated their professional lives to veterinary care.”
“Our goal is to allow veterinary professionals to focus on operating at the top of their profession while Rarebreed takes care of the rest,” said Sean Miller, COO of Rarebreed Veterinary Partners. “We believe this makes a significant difference not only for our patients, but also the employees within our network.”
“Dan and Sean’s leadership has been instrumental to Rarebreed’s rapid growth over the past three years,” said JP Gutfreund, managing partner at Halle Capital Management. “We have been thrilled to be part of the company’s journey and look forward to supporting its continued expansion as it seeks to improve the work experience for veterinary professionals across the country.”
“The Rarebreed team continues to impress us with the execution on its strategy and support of its partners in a high-growth environment,” said Jamie Manges, partner at Trilantic North America.
“We are enthusiastic to support the team with additional capital to continue investing to address the rising tide of demand for animal healthcare services,” added Ted Rosenwasser, principal at Trilantic North America.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP provided legal advice to Rarebreed in the transaction.